Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 27,885 | 3,767 | 0 | 0 | 0 |
| Gross Profit | 27,885 | 3,767 | 0 | 0 | 0 |
| Operating Expenses | 26,684 | 13,783 | 8,817 | 6,380 | 2,156 |
| Operating Income | 1,201 | -10,016 | -8,817 | -6,380 | -2,156 |
| Interest Expense | 493 | 453 | 403 | 253 | 0 |
| Other Income | 1,409 | 1,983 | 4,077 | 2,303 | 262 |
| Pre-tax Income | 2,117 | -8,486 | -5,143 | -4,330 | -1,894 |
| Income Tax | 80 | 0 | 0 | 0 | 0 |
| Net Income Continuous | 2,037 | -8,486 | -5,143 | -4,330 | -1,894 |
| Net Income | $2,037 | $-8,486 | $-5,143 | $-4,330 | $-1,894 |
| EPS Basic Total Ops | 0.08 | -0.36 | -0.39 | -1.23 | -0.89 |
| EPS Basic Continuous Ops | 0.08 | -0.35 | -0.22 | -1.23 | -0.89 |
| EPS Diluted Total Ops | 0.08 | -0.35 | -0.22 | -0.33 | -0.89 |
| EPS Diluted Continuous Ops | 0.08 | -0.35 | -0.22 | -0.33 | -0.89 |
| EBITDA(a) | $5,099 | $-7,242 | $-6,989 | $-5,103 | $-2,062 |